Our Biggest Event Yet!

Thank you for making Immuno-Oncology Summit 2018 the most successful year ever! Over 625 international scientists and executives came together this summer in Boston to share their cutting-edge research in the exciting, rapidly expanding field of immunotherapy and immuno-oncology.

Immuno-Oncology Summit 2018 by the Numbers

  • Record Attendance! 16% Attendee Growth since 2017. Third year of growth since event’s inception in 2016.
  • Over 400 companies from 28 nations represented.
  • C-Level Executives represent 30% of attendees.
  • 70% of delegates from Biotech and Pharma.
  • SOLD OUT Exhibit Hall hosted 40 booths and 40 scientific posters.

SAVE THE DATE!

The Immuno-Oncology Summit will return to Boston August 5-9, 2019 at the Westin Boston Waterfront. Check back this winter for program announcements and plans for what we hope will be an even more successful 2019 event!


Testimonials

“CHI’s 6th Annual IO Summit was a cutting-edge meeting, one of my favorites, as many collaboration connections were made out of this meeting. It is very well organized and a successful meeting.”

-Professor, Cancer Immunology, Northwestern University

“I found the conference excellent, with a good mix of academic and industry insight. Looking forward to your upcoming meetings.”

-Internal Medicine, Arizona Biodesign Institute

“CHI’s IO Summit 2018 was the best one yet. It had great speakers and it really stimulated good discussion. I think it incorporated all of the main topics and thought regarding Immunotherapy.”

-Director, Biomarker Laboratory, Massachusetts General Hospital Cancer Center



“I was impressed by the breadth and quality of the presentations. There was an excellent balance of presentations between preclinical R&D, translational medicine and clinical trials.”

Co-Founder & Executive Chairman, IGNITE Immunotherapy

"The smaller, more intimate – but well focused – partnering forum was much more effective for us than most of the larger conferences with thousands in attendance."

CEO, Siva Therapeutics, Inc.

This was a great experience, and I enjoyed being able to share my work as well as learn about all the new advances in immunotherapy. I highly enjoyed the conference, there were great panels full of amazing speakers. I definitely learned a lot!

PhD Candidate, Loyola University Chicago

View Photo Slideshow


About the Immuno-Oncology Summit

Join over 600 thought leaders at industry’s leading Immuno-Oncology event and learn about the latest research in a comprehensive 12-track program, network and build lasting collaborations with an international mix of delegates from industry and academia, and gain actionable solutions to drive your organization’s next-generation immunotherapy programs. Learn more.


Plenary Keynotes

CAR-T Therapy for B Cell Malignancies

Jennifer Brogdon, PhD, Director, Exploratory Immuno-Oncology, Novartis


Young CatherineWalking on the Moon: Reflections on the Work of the Cancer Moonshot and the Future of the Biden Cancer Initiative

Catharine Young, PhD, Senior Director, Science Policy, Biden Cancer Initiative


Short Courses

  • Bioinformatics for Immuno-Oncology and Translational Research
  • Next-Generation Immunotherapies: Part 1
  • Next-Generation Immunotherapies: Part 2
Learn more

For meeting questions or suggestions:

Julia Boguslavsky
Executive Director, Conferences
Cambridge Healthtech Institute
E: Juliab@healthtech.com

For partnering and sponsorship info:

Rod Eymael
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-247-6286
E: reymael@healthtech.com

For media and association partnerships:

Pete DeOlympio
Sr. Marketing Manager
Cambridge Healthtech Institute
T: (+1) 781-972-5415
E: peted@healthtech.com